IASLC
@iaslc.bsky.social
International Association for the Study of Lung Cancer
🎧 Available now!
Dr. Steven Liu is joined by Dr. Raffaele Califano and Dr. Jessica Menis for a case-based discussion on extensive-stage SCLC, reviewing recent advances and how they inform treatment decisions today.
Listen here: bit.ly/461LUWN
#LungCancerConsidered #ThoracicOncology
Dr. Steven Liu is joined by Dr. Raffaele Califano and Dr. Jessica Menis for a case-based discussion on extensive-stage SCLC, reviewing recent advances and how they inform treatment decisions today.
Listen here: bit.ly/461LUWN
#LungCancerConsidered #ThoracicOncology
February 17, 2026 at 10:12 PM
🎧 Available now!
Dr. Steven Liu is joined by Dr. Raffaele Califano and Dr. Jessica Menis for a case-based discussion on extensive-stage SCLC, reviewing recent advances and how they inform treatment decisions today.
Listen here: bit.ly/461LUWN
#LungCancerConsidered #ThoracicOncology
Dr. Steven Liu is joined by Dr. Raffaele Califano and Dr. Jessica Menis for a case-based discussion on extensive-stage SCLC, reviewing recent advances and how they inform treatment decisions today.
Listen here: bit.ly/461LUWN
#LungCancerConsidered #ThoracicOncology
What’s in store for #TTLC26? 🧬
The Conference Chairs share key programming highlights, breakthrough data to watch, and why this year’s meeting is one you won’t want to miss.
Get the preview in ILCN: bit.ly/3MoKSO4
#LCSM
The Conference Chairs share key programming highlights, breakthrough data to watch, and why this year’s meeting is one you won’t want to miss.
Get the preview in ILCN: bit.ly/3MoKSO4
#LCSM
February 13, 2026 at 7:26 PM
What’s in store for #TTLC26? 🧬
The Conference Chairs share key programming highlights, breakthrough data to watch, and why this year’s meeting is one you won’t want to miss.
Get the preview in ILCN: bit.ly/3MoKSO4
#LCSM
The Conference Chairs share key programming highlights, breakthrough data to watch, and why this year’s meeting is one you won’t want to miss.
Get the preview in ILCN: bit.ly/3MoKSO4
#LCSM
🎧 New #LungCancerConsidered episode
Dr. Molly Li leads a conversation with Dr. Shuben Li and Dr. Calvin S.H. Ng on surgical management of early-stage #NSCLC, including VATS, resection approaches, endobronchial therapy, and tubeless anesthesia. Listen now: bit.ly/464OFGN
#GlobalOncology #LungCancer
Dr. Molly Li leads a conversation with Dr. Shuben Li and Dr. Calvin S.H. Ng on surgical management of early-stage #NSCLC, including VATS, resection approaches, endobronchial therapy, and tubeless anesthesia. Listen now: bit.ly/464OFGN
#GlobalOncology #LungCancer
LCC in Cantonese: Updates in Surgical Approaches and Techniques in Early-Stage Lung Cancer | IASLC
As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with two expert card ...
bit.ly
February 13, 2026 at 6:27 PM
🎧 New #LungCancerConsidered episode
Dr. Molly Li leads a conversation with Dr. Shuben Li and Dr. Calvin S.H. Ng on surgical management of early-stage #NSCLC, including VATS, resection approaches, endobronchial therapy, and tubeless anesthesia. Listen now: bit.ly/464OFGN
#GlobalOncology #LungCancer
Dr. Molly Li leads a conversation with Dr. Shuben Li and Dr. Calvin S.H. Ng on surgical management of early-stage #NSCLC, including VATS, resection approaches, endobronchial therapy, and tubeless anesthesia. Listen now: bit.ly/464OFGN
#GlobalOncology #LungCancer
📈 Lung cancer survival is improving, but too many are still diagnosed late, and access to screening & testing isn’t equal across communities. We can do better. Read the new national report from the American Lung Association: bit.ly/45ZPyR7
February 12, 2026 at 11:35 PM
📈 Lung cancer survival is improving, but too many are still diagnosed late, and access to screening & testing isn’t equal across communities. We can do better. Read the new national report from the American Lung Association: bit.ly/45ZPyR7
Reposted by IASLC
Join us for the #IASLC 2026 Hot Topic Meeting on Resistance to Immunotherapy!
🗓️ June 25-27, 2026
📍 Dublin, Ireland
👉 ht26-iaslc.eventsair.site/full-program
@iaslc.bsky.social @patrickforde.bsky.social
🗓️ June 25-27, 2026
📍 Dublin, Ireland
👉 ht26-iaslc.eventsair.site/full-program
@iaslc.bsky.social @patrickforde.bsky.social
February 11, 2026 at 1:52 PM
Join us for the #IASLC 2026 Hot Topic Meeting on Resistance to Immunotherapy!
🗓️ June 25-27, 2026
📍 Dublin, Ireland
👉 ht26-iaslc.eventsair.site/full-program
@iaslc.bsky.social @patrickforde.bsky.social
🗓️ June 25-27, 2026
📍 Dublin, Ireland
👉 ht26-iaslc.eventsair.site/full-program
@iaslc.bsky.social @patrickforde.bsky.social
AI is rapidly changing the landscape of lung cancer care.
In the newest LCC episode, Dr. Narjust Florez speaks with Dr. @pateloncology.bsky.social about how AI is influencing patient care and experience, and the importance of staying informed as these tools evolve.
🎧 Listen here: bit.ly/3ZrrAKI
In the newest LCC episode, Dr. Narjust Florez speaks with Dr. @pateloncology.bsky.social about how AI is influencing patient care and experience, and the importance of staying informed as these tools evolve.
🎧 Listen here: bit.ly/3ZrrAKI
Will AI Take My Job? Discussing the Role of AI in Thoracic Oncology | IASLC
This episode of Lung Cancer Considered takes an in-depth look at AI in lung cancer care. Join host Dr. Narjust Florez and Dr. Sandip Patel for a discussion of t ...
bit.ly
February 10, 2026 at 7:56 PM
AI is rapidly changing the landscape of lung cancer care.
In the newest LCC episode, Dr. Narjust Florez speaks with Dr. @pateloncology.bsky.social about how AI is influencing patient care and experience, and the importance of staying informed as these tools evolve.
🎧 Listen here: bit.ly/3ZrrAKI
In the newest LCC episode, Dr. Narjust Florez speaks with Dr. @pateloncology.bsky.social about how AI is influencing patient care and experience, and the importance of staying informed as these tools evolve.
🎧 Listen here: bit.ly/3ZrrAKI
⏳ Regular registration closes tomorrow for the Targeted Therapies of Lung Cancer Conference (#TTLC26).
Join global experts to explore the latest data, practical strategies, and future directions in targeted lung cancer therapies.
🔗 Register now: www.ttlc-iaslc.org
Join global experts to explore the latest data, practical strategies, and future directions in targeted lung cancer therapies.
🔗 Register now: www.ttlc-iaslc.org
February 10, 2026 at 12:13 AM
⏳ Regular registration closes tomorrow for the Targeted Therapies of Lung Cancer Conference (#TTLC26).
Join global experts to explore the latest data, practical strategies, and future directions in targeted lung cancer therapies.
🔗 Register now: www.ttlc-iaslc.org
Join global experts to explore the latest data, practical strategies, and future directions in targeted lung cancer therapies.
🔗 Register now: www.ttlc-iaslc.org
New insights from Dr. Stephen Liu in ILCN spotlight zenocutuzumab as a potential first-line option for patients with NRG1-positive cancers.
Explore the article: bit.ly/3O1A09h
Explore the article: bit.ly/3O1A09h
Targeting NRG1 Fusions: A Potential Role for Zenocutuzumab as a First-Line Therapeutic Option - ILCN.org (ILCN/WCLC)
Dr. Stephen Liu recently highlighted the safety and efficacy of a targeted therapy for patients with NRG1-positive cancers with updated data from the ongoing eNRGy trial.
bit.ly
February 9, 2026 at 4:31 PM
New insights from Dr. Stephen Liu in ILCN spotlight zenocutuzumab as a potential first-line option for patients with NRG1-positive cancers.
Explore the article: bit.ly/3O1A09h
Explore the article: bit.ly/3O1A09h
Tomasik and Dziadziuszko conclude their two-part ILCN series by highlighting unresolved clinical questions and future directions for integrating HA-PCI and SRS into SCLC practice. Essential reading for oncology care teams and researchers.
Read now: bit.ly/4qrMhRV
Read now: bit.ly/4qrMhRV
Stereotactic Radiosurgery for Established Brain Metastases: Prospective Evidence - ILCN.org (ILCN/WCLC)
In the conclusion of this two-part series, Drs. Tomasik and Dziadziuszko highlight unresolved questions and future directions for integrating HA-PCI and SRS into practice for SCLC.
bit.ly
February 6, 2026 at 10:47 PM
Tomasik and Dziadziuszko conclude their two-part ILCN series by highlighting unresolved clinical questions and future directions for integrating HA-PCI and SRS into SCLC practice. Essential reading for oncology care teams and researchers.
Read now: bit.ly/4qrMhRV
Read now: bit.ly/4qrMhRV
What’s next for clinical research? 🧬
#TTLC26 is counting down, bringing sharp minds together to talk targeted therapies and the future of the field.
bit.ly/3KP8GtL
#TTLC26 is counting down, bringing sharp minds together to talk targeted therapies and the future of the field.
bit.ly/3KP8GtL
February 5, 2026 at 5:51 PM
What’s next for clinical research? 🧬
#TTLC26 is counting down, bringing sharp minds together to talk targeted therapies and the future of the field.
bit.ly/3KP8GtL
#TTLC26 is counting down, bringing sharp minds together to talk targeted therapies and the future of the field.
bit.ly/3KP8GtL
Calling early & mid-career investigators in Asia-Pacific!
IASLC, in partnership with the Journal of Thoracic Oncology, will host a Reviewer Workshop at #WCLC26.
Participants receive:
✔️ Free WCLC registration
✔️ Travel & accommodation support
✔️ Additional benefits
🔗 Apply here: bit.ly/4a8DTk7
IASLC, in partnership with the Journal of Thoracic Oncology, will host a Reviewer Workshop at #WCLC26.
Participants receive:
✔️ Free WCLC registration
✔️ Travel & accommodation support
✔️ Additional benefits
🔗 Apply here: bit.ly/4a8DTk7
February 3, 2026 at 5:41 PM
Calling early & mid-career investigators in Asia-Pacific!
IASLC, in partnership with the Journal of Thoracic Oncology, will host a Reviewer Workshop at #WCLC26.
Participants receive:
✔️ Free WCLC registration
✔️ Travel & accommodation support
✔️ Additional benefits
🔗 Apply here: bit.ly/4a8DTk7
IASLC, in partnership with the Journal of Thoracic Oncology, will host a Reviewer Workshop at #WCLC26.
Participants receive:
✔️ Free WCLC registration
✔️ Travel & accommodation support
✔️ Additional benefits
🔗 Apply here: bit.ly/4a8DTk7
Looking for preclinical cancer model data?
VIKTOR is live and ready to use.
👉 www.iaslc.org/viktor
#PreclinicalModels #ResearchTools
VIKTOR is live and ready to use.
👉 www.iaslc.org/viktor
#PreclinicalModels #ResearchTools
February 2, 2026 at 3:03 PM
Looking for preclinical cancer model data?
VIKTOR is live and ready to use.
👉 www.iaslc.org/viktor
#PreclinicalModels #ResearchTools
VIKTOR is live and ready to use.
👉 www.iaslc.org/viktor
#PreclinicalModels #ResearchTools
Heading to #WCLC26?
We’re launching travel and education awards to support early career professionals, researchers in developing countries, nurses, allied health professionals, and patient advocates. Learn more & apply today: bit.ly/4qNoGfb
We’re launching travel and education awards to support early career professionals, researchers in developing countries, nurses, allied health professionals, and patient advocates. Learn more & apply today: bit.ly/4qNoGfb
January 30, 2026 at 6:32 PM
Heading to #WCLC26?
We’re launching travel and education awards to support early career professionals, researchers in developing countries, nurses, allied health professionals, and patient advocates. Learn more & apply today: bit.ly/4qNoGfb
We’re launching travel and education awards to support early career professionals, researchers in developing countries, nurses, allied health professionals, and patient advocates. Learn more & apply today: bit.ly/4qNoGfb
Managing complex #lungcancer cases takes true multidisciplinary coordination.
Join our Feb 26 #webinar to learn practical strategies for mediastinal staging, post-operative radiotherapy, and treatment sequencing after induction chemo-immunotherapy.
Register: bit.ly/4bqGS9G
Join our Feb 26 #webinar to learn practical strategies for mediastinal staging, post-operative radiotherapy, and treatment sequencing after induction chemo-immunotherapy.
Register: bit.ly/4bqGS9G
January 27, 2026 at 9:49 PM
Managing complex #lungcancer cases takes true multidisciplinary coordination.
Join our Feb 26 #webinar to learn practical strategies for mediastinal staging, post-operative radiotherapy, and treatment sequencing after induction chemo-immunotherapy.
Register: bit.ly/4bqGS9G
Join our Feb 26 #webinar to learn practical strategies for mediastinal staging, post-operative radiotherapy, and treatment sequencing after induction chemo-immunotherapy.
Register: bit.ly/4bqGS9G
Looking to exchange insights in thoracic oncology?
Thoracic Circle connects clinicians and researchers from around the world in one focused community.
Get started: bit.ly/491gZuc
Thoracic Circle connects clinicians and researchers from around the world in one focused community.
Get started: bit.ly/491gZuc
January 23, 2026 at 5:55 PM
Looking to exchange insights in thoracic oncology?
Thoracic Circle connects clinicians and researchers from around the world in one focused community.
Get started: bit.ly/491gZuc
Thoracic Circle connects clinicians and researchers from around the world in one focused community.
Get started: bit.ly/491gZuc
Patient advocate Kate Sinclair highlights the importance of compassion and clear communication in a new ILCN article.
Read her perspective now: bit.ly/49Fo303
Read her perspective now: bit.ly/49Fo303
The Importance of Compassion and Clear Communication: A Patient Advocate Perspective - ILCN.org (ILCN/WCLC)
Patient advocate Kate Sinclair shares why communication is one of the most important tools for improving the patient experience during their lung cancer journey.
bit.ly
January 22, 2026 at 7:33 PM
Patient advocate Kate Sinclair highlights the importance of compassion and clear communication in a new ILCN article.
Read her perspective now: bit.ly/49Fo303
Read her perspective now: bit.ly/49Fo303
📰 ICYMI: New updates from the US FDA for risvutatug rezetecan and the subcutaneous amivantamab plus hyaluronidase-lpuj.
Read the latest in ILCN: bit.ly/3YCZPP3
Read the latest in ILCN: bit.ly/3YCZPP3
In Brief for January 14, 2026 - ILCN.org (ILCN/WCLC)
The US FDA grants special designation to risvutatug rezetecan for SCLC and approves the subcutaneous formulation of amivantamab plus hyaluronidase-lpuj for EGFR+ NSCLC.
bit.ly
January 20, 2026 at 7:14 PM
📰 ICYMI: New updates from the US FDA for risvutatug rezetecan and the subcutaneous amivantamab plus hyaluronidase-lpuj.
Read the latest in ILCN: bit.ly/3YCZPP3
Read the latest in ILCN: bit.ly/3YCZPP3
Discussão internacional sobre câncer de pulmão, em português!
This episode is part of IASLC’s Lung Cancer Considered World Language Series and focuses on the junior faculty perspective, hosted by Maria Cecilia Mathias with Maria Thereza Starling and Paula Duarte.
Listen now: bit.ly/Port-jfp
This episode is part of IASLC’s Lung Cancer Considered World Language Series and focuses on the junior faculty perspective, hosted by Maria Cecilia Mathias with Maria Thereza Starling and Paula Duarte.
Listen now: bit.ly/Port-jfp
January 16, 2026 at 5:33 PM
Discussão internacional sobre câncer de pulmão, em português!
This episode is part of IASLC’s Lung Cancer Considered World Language Series and focuses on the junior faculty perspective, hosted by Maria Cecilia Mathias with Maria Thereza Starling and Paula Duarte.
Listen now: bit.ly/Port-jfp
This episode is part of IASLC’s Lung Cancer Considered World Language Series and focuses on the junior faculty perspective, hosted by Maria Cecilia Mathias with Maria Thereza Starling and Paula Duarte.
Listen now: bit.ly/Port-jfp
Experts outline how #Poland aims to reduce #lungcancer mortality while addressing one of the nation’s most persistent health challenges: tobacco dependence.
Read more in ILCN: bit.ly/4qtSi1k
Read more in ILCN: bit.ly/4qtSi1k
A Comprehensive Framework: Integrating Smoking Cessation into LCS - ILCN.org (ILCN/WCLC)
Experts outline how Poland aims to reduce lung cancer mortality while addressing one of the nation’s most persistent health challenges: tobacco dependence.
bit.ly
January 15, 2026 at 6:28 PM
Experts outline how #Poland aims to reduce #lungcancer mortality while addressing one of the nation’s most persistent health challenges: tobacco dependence.
Read more in ILCN: bit.ly/4qtSi1k
Read more in ILCN: bit.ly/4qtSi1k
Tomasik and Dziadziuszko highlight a shift in SCLC toward brain-sparing radiation that aims to improve disease control and protect cognitive function.
Explore their discussion on ILCN: bit.ly/4pB3esr
Explore their discussion on ILCN: bit.ly/4pB3esr
Modern Brain Radiotherapy in SCLC: Integrating Hippocampal Avoidance and Stereotactic Precision - ILCN.org (ILCN/WCLC)
Drs. Tomasik and Dziadziuszko discuss how the SCLC field is shifting toward brain-sparing techniques to maximize disease control, as well as cognitive preservation.
bit.ly
January 14, 2026 at 9:55 PM
Tomasik and Dziadziuszko highlight a shift in SCLC toward brain-sparing radiation that aims to improve disease control and protect cognitive function.
Explore their discussion on ILCN: bit.ly/4pB3esr
Explore their discussion on ILCN: bit.ly/4pB3esr
Complex lung cancer care demands real multidisciplinary coordination. Join our Feb 26 webinar to explore mediastinal staging, post-operative radiotherapy, and treatment sequencing after induction chemo-immunotherapy.
Learn practical strategies to close practice gaps.
Register: bit.ly/4bqGS9G
Learn practical strategies to close practice gaps.
Register: bit.ly/4bqGS9G
January 12, 2026 at 8:22 PM
Complex lung cancer care demands real multidisciplinary coordination. Join our Feb 26 webinar to explore mediastinal staging, post-operative radiotherapy, and treatment sequencing after induction chemo-immunotherapy.
Learn practical strategies to close practice gaps.
Register: bit.ly/4bqGS9G
Learn practical strategies to close practice gaps.
Register: bit.ly/4bqGS9G
Reposted by IASLC
Really enjoyed this conversation with @stephenvliu.bsky.social & @nealaugenstein.bsky.social - thank you!
🎉 We’re kicking off the new year with a new podcast episode!
This first episode of the year explores how media influences lung cancer awareness and public perception, and why changing the narrative matters.
Listen and learn more: bit.ly/3L0Cnbl
#NewYear #LungCancerAwareness #Podcast
This first episode of the year explores how media influences lung cancer awareness and public perception, and why changing the narrative matters.
Listen and learn more: bit.ly/3L0Cnbl
#NewYear #LungCancerAwareness #Podcast
Impact of the Media on Lung Cancer Awareness and Perception | IASLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by CNN Medical Correspondent Meg Tirrell and WTOP reporter Neal Augenstein to discuss ...
bit.ly
January 8, 2026 at 9:16 PM
Really enjoyed this conversation with @stephenvliu.bsky.social & @nealaugenstein.bsky.social - thank you!
IASLC invites qualified members in Latin America to apply or nominate a colleague to join the Latin America Regional Group, supporting regional growth and the thoracic oncology community.
Applications close February 6, 2026
Learn more: bit.ly/4qFOhGr
Applications close February 6, 2026
Learn more: bit.ly/4qFOhGr
January 9, 2026 at 4:49 PM
IASLC invites qualified members in Latin America to apply or nominate a colleague to join the Latin America Regional Group, supporting regional growth and the thoracic oncology community.
Applications close February 6, 2026
Learn more: bit.ly/4qFOhGr
Applications close February 6, 2026
Learn more: bit.ly/4qFOhGr
New on #ILCN: IASLC Spotlight, Global Policy & Partnerships Committee!
Learn how global experts are shaping policies to improve lung cancer prevention, early detection, and access to care worldwide.
bit.ly/4jyCUhz
Learn how global experts are shaping policies to improve lung cancer prevention, early detection, and access to care worldwide.
bit.ly/4jyCUhz
IASLC Spotlight: Global Policy and Partnerships Committee - ILCN.org (ILCN/WCLC)
In a Q&A with ILCN, Dr. Gilberto de Lima Lopes, Committee Chair, details how the committee is working to address the most significant global challenges in lung cancer care.
bit.ly
January 8, 2026 at 5:08 PM
New on #ILCN: IASLC Spotlight, Global Policy & Partnerships Committee!
Learn how global experts are shaping policies to improve lung cancer prevention, early detection, and access to care worldwide.
bit.ly/4jyCUhz
Learn how global experts are shaping policies to improve lung cancer prevention, early detection, and access to care worldwide.
bit.ly/4jyCUhz
As the year begins, join the conversation around new clinical research findings and advances in targeted therapies at #TTLC26.
Registration is open now: bit.ly/3KP8GtL
Registration is open now: bit.ly/3KP8GtL
January 7, 2026 at 5:32 PM
As the year begins, join the conversation around new clinical research findings and advances in targeted therapies at #TTLC26.
Registration is open now: bit.ly/3KP8GtL
Registration is open now: bit.ly/3KP8GtL